Fibroadenomas are benign breast masses that often occur in adolescence and young adulthood. Primary management options include observation or surgical excision, but little is known about long-term outcomes after fibroadenoma excision in adolescents.
Abstract
Fibroadenomas are benign breast masses that often occur in adolescence and young adulthood. Primary management options include observation or surgical excision, but little is known about long-term outcomes after fibroadenoma excision in adolescents.
In the present study, we reviewed the medical records of females aged 13-35 years who underwent fibroadenoma excision at our institution from 1986 through 2010.
Patients were included if they had excision of at least 1 fibroadenoma (confirmed by histopathology) smaller than 5 cm in maximal diameter. We collected information pertaining to clinical presentation, management, and outcomes. In addition, an investigator-designed long-term outcome survey was sent to 138 eligible participants to assess patient satisfaction, as well as the recurrence of fibroadenoma, and the need or desire for further surgical intervention. Most patients (126 of 138) underwent 1 operation for fibroadenoma excision. Three women underwent immediate breast reconstruction at fibroadenoma excision. Fifty-seven patients completed the investigator-designed survey (response rate, 41.3%) with a median follow-up time of 13.5 (range, 2.0-26.7) years. Nine of 55 patients (16.4%) reported postoperative breast asymmetry and the desire to pursue reconstructive surgery. Three survey responders reported breast pain. Fourteen of 56 women (25.0%) reported the diagnosis of 1 or more additional fibroadenomas after the initial excision; another 7 reported recurrence of the mass at the site of excision. Most survey participants were satisfied with the aesthetic outcome of their fibroadenoma excision; however, a small proportion believed that they would benefit from reconstructive breast surgery. The recurrence and development of additional fibroadenomas should be addressed by providers during counseling for treatment options and postoperative follow-up.
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| INTRODUCTION
A fibroadenoma is a benign breast mass that most commonly occurs during adolescence or early adulthood; it is the most frequently diagnosed and surgically treated breast mass in this age group. 1, 2 Fibroadenomas are caused by overgrowth of the connective tissue stroma of the breast lobule, 3 which may result from alterations in hormonal sensitivity. 4 
| MATERIALS AND METHODS
The Mayo Clinic Institutional Review Board approved this study.
We used our institution's pathology database to identify potential patients for inclusion. We queried the database for the terms In addition, after obtaining informed consent (and assent when required), we administered an investigator-designed survey to assess long-term outcomes of fibroadenoma excision among our patient sample. Surveys were conducted by mail or telephone interview. A hard copy of the survey was mailed to the patients. If study participants did not respond after two mail attempts, they received a telephone call and were invited to complete the survey questions over the phone. The survey aimed to determine postoperative outcomes, including fibroadenoma recurrence, the incidence of additional fibroadenomas, the need for further excisions, and breast pain perceived to be related to fibroadenoma excision. Patients were asked about preoperative and postoperative breast asymmetry and the need or desire for further breast surgery. We also inquired about a personal and family history of breast-related disease, including breast cancer.
Statistical analyses were performed with SAS version 9.4 (SAS Institute Inc, Cary, North Carolina). Clinical information was compared between survey responders and nonresponders with chi-square tests for categorical variables and t tests or Wilcoxon rank sum tests for continuous variables. 
| RESULTS

| Presentation
| Intermediate and long-term outcomes
Of the 138 patients, 57 (41.3%) completed the long-term outcomes survey. Among these patients, mean (SD) age at excision was 20.8 (2.9) years (range, 13.3-25.5 years), which was not statistically significantly different from the average age of nonresponders (P = 0.89; Table 1 ).
Average size of the fibroadenomas at presentation was similar in In the survey, seven patients (7 of 57; 12.3%) reported same-site fibroadenoma recurrence; 1 underwent a second excision. In addition, 14 patients (14 of 56; 25.0%) reported having at least 1 additional fibroadenoma develop after the first excision (Table 2) . Among the 57 responders, there were no statistically significant differences in patient age or fibroadenoma size between patients who had recurring or new fibroadenomas and those who did not (P > 0.05).
Five patients (5 of 57; 8.8%) reported preoperative breast asymmetry, and 9 (9 of 55; 16.4%) reported iatrogenic breast asymmetry after fibroadenoma excision (Table 2) .
Three patients (3 of 57; 5.3%) underwent breast reconstruction surgery at the time of initial excision, leading to complete resolution of their symptoms. Another 3 (3 of 54; 5.6%), after consulting with their physician, planned to undergo breast reconstruction in the near future ( Table 2) . Seven patients (7 of 51; 13.7%) reported a desire to undergo breast reconstruction in the future but had not yet discussed this with their physician.
Three patients (3 of 57; 5.3%) reported long-term postoperative breast pain. Two patients (2 of 56; 3.6%) have received breast cancer diagnoses. Care from a physician relating to breast health issues was being sought by 17 women (17 of 54; 31.5%) ( Table 2 ).
| DISCUSSION
Little is known about the long-term outcomes of fibroadenoma excision in adolescent and young adult women. We report on 138 patients with a mean age of 20.9 years and an average fibroadenoma size of 2.8 cm at presentation. Long-term follow-up data were available for 57 of these patients.
| Recurrence rate and need for additional excision
Of the 57 participants who responded to the survey, approximately 12% experienced recurrence of the initially removed fibroadenoma at the same site as the excisional biopsy for the original fibroadenoma.
A quarter of surveyed women experienced recurrence of 1 or more Pain was rated as 2 out of 10 for 1 of these patients, and 4 out of 10 for the other 2 patients.
c All 3 patients reported that the issue was resolved.
| Risk of breast malignancy
In the present study, 2 of 56 survey responders received a diagnosis of breast cancer after their fibroadenoma excision. One had no family history of breast cancer, and the other did not know about the incidence of breast cancer in her family. In noncomplex fibroadenomas, particularly in patients without a family history of breast cancer, the risk of breast carcinoma is reported to be low. 14 Many of the studies on this topic were published several decades ago, and there is a need for more recent work. Malignant transformation within a fibroadenoma ranges from 0.002% to 0.0125%. 17, 18 In women younger than 25, the risk of missing breast cancer in a fibroadenoma diagnosed from physical examination, sonography, and fine-needle aspiration ranges from 1 in 229 to 1 in 700. 19 Although we did not exclude patients with 5 or more fibroadenomas, we did not encounter any such patients for inclusion in the study.
When patients have multiple fibroadenomas, diagnosis and management are often more challenging.
The majority of our patients expressed overall satisfaction with the aesthetic outcome of their fibroadenoma excision. However, a small proportion of patients believed that they would benefit from reconstructive breast surgery. The recurrence and development of additional fibroadenomas can be articulated by providers during counseling for treatment options and postoperative follow-up.
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